NSCLC (Non-small Cell Lung Carcinoma) trials recruiting in Connecticut

Fewer than 3 recruiting trials found.

All NSCLC (Non-small Cell Lung Carcinoma) trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
  NCT06881784 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven